Abstract:Background Noncommunicable diseases (NCDs) have become the main public health concern worldwide. With rapid economic development and changes in lifestyles, the burden of NCDs in China is increasing dramatically every year. Monitoring is a critical measure for NCDs control and prevention. However, because of the lack of regional representativeness, unsatisfactory data quality, and inefficient data sharing and utilization, the existing surveillance systems and surveys in China cannot track the status and transition of NCDs epidemic. Objective To efficaciously track NCDs epidemic in China, this pilot program conducted in Ningbo city by the Chinese Center for Disease Control and Prevention (CDC) aimed to develop an innovative model for NCDs surveillance and management: the integrated noncommunicable disease collaborative management system (NCDCMS). Methods This Ningbo model was designed and developed through a 3-level (county/district, municipal, and provincial levels) direct reporting system based on the regional health information platform. The uniform data standards and interface specifications were established to connect different platforms and conduct data exchanges. The performance of the system was evaluated based on the 9 attributes of surveillance system evaluation framework recommended by the US CDC. Results NCDCMS allows automatic NCDs data exchanging and sharing via a 3-level public health data exchange platform in China. It currently covers 201 medical institutions throughout the city. Compared with previous systems, automatic popping up of the report card, automatic patient information extraction, and real-time data exchange process have highly improved the simplicity and timeliness of the system. The data quality meets the requirements to monitor the incidence trend of NCDs accurately, and the comprehensive data types obtained from the database (ie, directly from the 3-level platform on the data warehouse) also provide a useful information to conduct scientific studies. So far, 98.1% (201/205) of medical institutions across Ningbo having been involved in data exchanges with the model. Evaluations of the system performance showed that NCDCMS has high levels of simplicity, data quality, acceptability, representativeness, and timeliness. Conclusions NCDCMS completely reshaped the process of NCD surveillance reporting and had unique advantages, which include reducing the work burden of different stakeholders by data sharing and exchange, eliminating unnecessary redundancies, reducing the amount of underreporting, and structuring population-based cohorts. The Ningbo model will be gradually promoted elsewhere following this success of the pilot project, and is expected to be a milestone in NCDs surveillance, control, and prevention in China.

Introduction of Common Data Model in United States FDA Mini-sentinel and Its Enlightenment to China

The Principle and the Design Framework of Over-the-counter Pharmaceutical Sales Surveillance

A Surveillance Platform of Antimicrobial Use in Hospital Based on Defined Daily Dose

Analysis of a Pharmacist-Led Adverse Drug Event Management Model for Pharmacovigilance in an Academic Medical Center Hospital in China

Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan

Design and development of a clinical data exchange system based on ensemble integration platform

Detecting Adverse Drug Event Signals from a Clinical CaseBase.

A Computational Method to Quantitatively Measure Pediatric Drug Safety Using Electronic Medical Records

Feasibility of Post-Marketing Active Safety Surveillance for Pediatric Medication Based on Big Medical Data: a Survey on Information Systems in 17 Children′s Hospitals in China

Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China

Surveillance of Noncommunicable Disease Epidemic Through the Integrated Noncommunicable Disease Collaborative Management System: Feasibility Pilot Study Conducted in the City of Ningbo, China

On standardization of basic datasets of electronic medical records in traditional Chinese medicine

Release of the National Healthcare Big Data in China: a Historic Leap in Clinical Research

Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment

Development Trends of the Post-Marketing Drug Safety Surveillance Systems in EU and US

[Progress and prospects of safety assessment methods of medicinal and food homologous substances]

Pharmacovigilance in China: Current Situation, Successes and Challenges

[Active Surveillance of Adverse Drug Reaction in the Era of Big Data: Challenge and Opportunity for Control Selection].

Pharmacovigilance in China: development and challenges

Interpretation of the Drug Post-marketing Intensive Surveillance Policy in China

Research of data warehouse established methods based on civil aviation medicine certification management information system